Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Glycosylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Pd-catalyzed route offers high beta-selectivity and yield for pharmaceutical intermediates. Enables cost reduction and supply chain reliability for global buyers.
Patent CN106543244A details enzymatic synthesis of galactosyl salidroside. Offers high yield, mild conditions, and cost-effective manufacturing for pharmaceutical supply chains.
Advanced stereospecific synthesis of beta-thymidine via CN1055293C. Offers cost reduction in API manufacturing with high purity and scalable industrial processes.
Patent CN103087132A reveals oxidizing agent method for beta-nucleosides. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN1376159A details a high-yield Etoposide synthesis using TMSOTf. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN1910194A details a mercury-free spongosine synthesis route offering high purity and scalability for cost reduction in API manufacturing.
Patent CN112724180A reveals a high-yield chemical route for beta-nicotinamide mononucleotide, offering cost reduction and scalable manufacturing for global supply chains.
Novel patent CN110183427A offers efficient synthesis for pharmaceutical intermediates. Reduces toxic reagents and improves total yield to 42.2% for scalable production.
Patent CN106831927A details high-yield Astragaloside IV synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN101279993A details a modular Suzuki coupling route for 3-aryl-8-hydroxychromone derivatives, offering cost-effective API intermediate manufacturing.
Patent CN108440473A reveals a high-yield synthesis for Marangucycline B intermediates, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Novel stereoselective method for 4-MU glycosides using peracetyl sugars. Enhances purity and supply chain reliability for diagnostic reagents.
Patent CN101279993B details a robust Suzuki coupling route for 3-aryl-8-hydroxychromone derivatives. Discover cost-effective manufacturing strategies for alpha-glucosidase inhibitors.
Patent CN111377989B reveals a high-selectivity synthesis for decitabine intermediates, offering superior beta-isomer ratios and scalable purification for cost-effective API manufacturing.
Patent CN108794653B discloses synthetic fucosylated chondroitin sulfate clusters with defined structures. Offers cost reduction in anticoagulant manufacturing and reliable supply chain solutions.
Advanced preparation method for 4-demethoxy-4-aminoanthracycline compounds via novel sulfonate intermediates. Enhances purity and supply chain reliability for API manufacturing.
Patent CN106350565A details enzymatic production of Ginsenoside Rh2. Discover cost-effective, scalable supply chain solutions for high-purity pharmaceutical intermediates.
Novel synthetic route for apigenin-7-O-glucoside-4'-O-rhamnoside intermediates. Overcomes extraction limits with high purity, scalable process for API manufacturing.
Patent CN101712668B details a scalable synthetic route for apigenin glycosides, offering high purity and yield compared to plant extraction for reliable supply.
Novel silanization route for Decitabine intermediates offering high purity and industrial scalability without column chromatography.